Blood, Cellular, and Tissular Calcineurin Inhibitors Pharmacokinetic–Pharmacodynamic Relationship in Heart Transplant Recipients: The INTRACAR Study
暂无分享,去创建一个
C. Chabanne | F. Lemaitre | B. Laviolle | B. Lelong | B. Turlin | E. Flécher | M. Roussel | M. Verdier | C. Tron | M. Desille-Dugast | Gwendal Coste | François Le Gall
[1] M. Durlik,et al. Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy , 2021, Pharmaceutics.
[2] K. Khush,et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] K. Kaku,et al. Development and Validation of A Liquid Chromatography–Tandem Mass Spectrometry Method to Simultaneously Measure Tacrolimus and Everolimus Concentrations in Kidney Allograft Biopsies After Kidney Transplantation , 2021, Therapeutic drug monitoring.
[4] D. Hesselink,et al. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology. , 2021, Best practice & research. Clinical gastroenterology.
[5] G. Russ,et al. Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients , 2021, British journal of clinical pharmacology.
[6] D. Hesselink,et al. Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients , 2020, British journal of clinical pharmacology.
[7] F. Lemaitre,et al. A simple and fast liquid chromatography tandem mass spectrometry method to determine cyclosporine A concentrations in endomyocardial biopsies. , 2020, Journal of pharmaceutical and biomedical analysis.
[8] M. Molinaro,et al. Development and validation of a combined enzymatic-digestion/mass spectrometry assay for Tacrolimus quantitation in cardiac biopsies. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[9] D. Hesselink,et al. Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) Expert Panel. , 2020, Therapeutic drug monitoring.
[10] Y. Bentata. Tacrolimus: 20 years of use in adult kidney transplantation; what we should know about its nephrotoxicity. , 2020, Artificial organs.
[11] U. Christians,et al. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report , 2019, Therapeutic drug monitoring.
[12] A. Åsberg,et al. Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies , 2018, Therapeutic drug monitoring.
[13] J. Kobashigawa,et al. Immunosuppression and adult heart transplantation: emerging therapies and opportunities , 2017, Expert review of cardiovascular therapy.
[14] V. Haufroid,et al. Intra-cellular immunosuppressive drugs monitoring: A step forward towards better therapeutic efficacy after organ transplantation? , 2016, Pharmacological research.
[15] Deepak L. Bhatt,et al. Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation. , 2016, Journal of the American College of Cardiology.
[16] K. Boudjema,et al. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. , 2015, Clinical biochemistry.
[17] F. Lemaitre,et al. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients. , 2013, Clinical biochemistry.
[18] G. Russ,et al. Validation of an LC–MS/MS Method to Measure Tacrolimus in Rat Kidney and Liver Tissue and Its Application to Human Kidney Biopsies , 2013, Therapeutic drug monitoring.
[19] A. Åsberg,et al. Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients , 2013, Transplantation research.
[20] N. Zahr,et al. Everolimus quantification in peripheral blood mononuclear cells using ultra high performance liquid chromatography tandem mass spectrometry. , 2012, Journal of pharmaceutical and biomedical analysis.
[21] V. Haufroid,et al. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[22] G. Russ,et al. Measurement of Cyclosporine A in Rat Tissues and Human Kidney Transplant Biopsies—A Method Suitable for Small (<1 mg) Samples , 2011, Therapeutic drug monitoring.
[23] Thierry Fest,et al. Refining the white blood cell differential: The first flow cytometry routine application , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[24] V. Haufroid,et al. CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation. , 2010, Pharmacogenomics.
[25] A. Åsberg,et al. Declining Intracellular T-Lymphocyte Concentration of Cyclosporine A Precedes Acute Rejection in Kidney Transplant Recipients , 2008, Transplantation.
[26] P. Halloran,et al. Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.
[27] V. Lelong-Boulouard,et al. Cyclosporine monitoring in peripheral blood mononuclear cells: feasibility and interest. A prospective study on 20 renal transplant recipients. , 2007, Transplantation proceedings.
[28] O. Ciccarelli,et al. Validation of a Liquid Chromatography-Mass Spectrometric Assay for Tacrolimus in Liver Biopsies After Hepatic Transplantation: Correlation With Histopathologic Staging of Rejection , 2007, Therapeutic drug monitoring.
[29] Silviu Itescu,et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] C. Staatz,et al. Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation , 2004, Clinical pharmacokinetics.
[31] G. Gores,et al. Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue , 1995, Hepatology.
[32] R. Wiesner,et al. Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection , 1992, Hepatology.